Pfizer Spends $700 Million Buying Maker of Liquid ADHD Drug
In a deal that could be worth up to $700 million, Pfizer Inc. (PFE) plans to acquire the developer of a drug for attention-deficit/hyperactivity disorder. The company announced the news on Monday. This agreement marks Pfizer’s entry to the ADHD treatment market. Shire PLC (SHP.LN) and Johnson & Johnson (JNJ) have been dominant with their […]
2 min read